Skip to content

Assessment of Research Digest Impact for Minority with Prostate Cancer, MiCAP Phase III Study

Minority Prostate Cancer (MiCaP) Phase III (Aim 3): Assessment of Research Digest Impact

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05895279
Acronym
MiCaP
Enrollment
220
Registered
2023-06-08
Start date
2021-08-02
Completion date
2021-10-01
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Carcinoma

Brief summary

This phase III trial determines how well the Minority Prostate Cancer (MiCaP) Research Digest works in providing information to black men about the latest prostate cancer research. MiCaP Research Digest may be an effective method to help people learn about prostate cancer.This goal of this trial is to create educational programming that helps Black men make informed decisions about their prostate healthcare since Black men are diagnosed with prostate cancer more than any other race or ethnicity.

Detailed description

PRIMARY OBJECTIVE: I. To develop a research dissemination program, the Minority Prostate Cancer (MiCaP) Research Digest, which will spread information about CaP scientific discoveries, evidence-based interventions, and open clinical trials instantly among black males (BM). OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants watch MiCaP Research Digest video on study. Participants complete a survey throughout the trial. ARM II: Participants watch an alternative video on study. Participants complete a survey throughout the trial.

Interventions

OTHERMedia Intervention

Watch MiCaP Research Digest video

OTHERSurvey Administration

Complete survey

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
35 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Identify as a Black male * Between the ages of 35 and 70 * For virtual data collection, have access to the internet and Zoom (if joining study online) * For virtual data collection, reside anywhere in the U.S. * For in-person data collection, reside in one of the nine (9) catchment areas of the Mayo Clinic Cancer Center: Baker, Duval, Nassau, Clay, St. John's, Putnam, Flagler, Volusia and Brevard

Exclusion criteria

* Identify as a race or ethnicity that is not Black * Identify as female * Be younger than age 35 and older than age 70 * Lack access to internet and Zoom (if joining study online)

Design outcomes

Primary

MeasureTime frameDescription
Change in perception of access to medical services and general healthBaseline, 1 hour after video interventionUsing the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 10 questions regarding access to medical services and general health with a yes/no response.
Change in perception in participation with clinical trials about prostate cancerBaseline, 1 hour after video interventionUsing the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 10 questions regarding views on participating in clinical trials about prostate cancer with a yes/no response.
Change in perception of familiarity with prostate cancer researchBaseline, 1 hour after video interventionUsing the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 5 questions regarding views on participating in clinical trials about prostate cancer with a true/false/don't know response.
Change in perception of familiarity with a research study protocolBaseline, 1 hour after video interventionUsing the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 5 questions regarding information about a study protocol with a true/false/don't know response.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026